<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Support Care Cancer</journal-id><journal-id journal-id-type="iso-abbrev">Support Care Cancer</journal-id><journal-title-group><journal-title>Supportive Care in Cancer</journal-title></journal-title-group><issn pub-type="ppub">0941-4355</issn><issn pub-type="epub">1433-7339</issn><publisher><publisher-name>Springer Berlin Heidelberg</publisher-name><publisher-loc>Berlin/Heidelberg</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">25680762</article-id><article-id pub-id-type="pmc">4519631</article-id><article-id pub-id-type="publisher-id">2622</article-id><article-id pub-id-type="doi">10.1007/s00520-015-2622-z</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Article</subject></subj-group></article-categories><title-group><article-title>Moderators of the effects of group-based physical exercise on cancer survivors&#x02019; quality of life</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Kalter</surname><given-names>Joeri</given-names></name><xref ref-type="aff" rid="Aff1"/></contrib><contrib contrib-type="author"><name><surname>Buffart</surname><given-names>Laurien M.</given-names></name><xref ref-type="aff" rid="Aff1"/></contrib><contrib contrib-type="author"><name><surname>Korstjens</surname><given-names>Irene</given-names></name><xref ref-type="aff" rid="Aff2"/><xref ref-type="aff" rid="Aff3"/></contrib><contrib contrib-type="author"><name><surname>van Weert</surname><given-names>Ellen</given-names></name><xref ref-type="aff" rid="Aff4"/></contrib><contrib contrib-type="author"><name><surname>Brug</surname><given-names>Johannes</given-names></name><xref ref-type="aff" rid="Aff1"/></contrib><contrib contrib-type="author"><name><surname>Verdonck-de Leeuw</surname><given-names>Irma M.</given-names></name><xref ref-type="aff" rid="Aff5"/><xref ref-type="aff" rid="Aff6"/></contrib><contrib contrib-type="author"><name><surname>Mesters</surname><given-names>Ilse</given-names></name><xref ref-type="aff" rid="Aff7"/></contrib><contrib contrib-type="author"><name><surname>van den Borne</surname><given-names>Bart</given-names></name><xref ref-type="aff" rid="Aff7"/></contrib><contrib contrib-type="author"><name><surname>Hoekstra-Weebers</surname><given-names>Josette E. H. M.</given-names></name><xref ref-type="aff" rid="Aff8"/><xref ref-type="aff" rid="Aff9"/></contrib><contrib contrib-type="author"><name><surname>Ros</surname><given-names>Wynand J. G.</given-names></name><xref ref-type="aff" rid="Aff10"/></contrib><contrib contrib-type="author" corresp="yes"><name><surname>May</surname><given-names>Anne M.</given-names></name><address><phone>+31 (0)88 7551132</phone><email>a.m.may@umcutrecht.nl</email></address><xref ref-type="aff" rid="Aff10"/></contrib><aff id="Aff1"><label/>EMGO+ Institute, Department of Epidemiology and Biostatistics, VU University Medical Center Amsterdam, Amsterdam, The Netherlands </aff><aff id="Aff2"><label/>Research Department Midwifery Science, Faculty of Midwifery Education and Studies, Zuyd University, Maastricht, The Netherlands </aff><aff id="Aff3"><label/>Department of Epidemiology/CAPHRI, Maastricht University, Maastricht, The Netherlands </aff><aff id="Aff4"><label/>Centre for Rehabilitation, University Medical Center Groningen, Groningen, The Netherlands </aff><aff id="Aff5"><label/>Department of Clinical Psychology, VU University, Amsterdam, The Netherlands </aff><aff id="Aff6"><label/>Department of Otolaryngology&#x02013;Head &#x00026; Neck Surgery, VU University Medical Center, Amsterdam, The Netherlands </aff><aff id="Aff7"><label/>Department of Health Promotion/CAPHRI, Maastricht, The Netherlands </aff><aff id="Aff8"><label/>Comprehensive Cancer Center Netherlands, Groningen, The Netherlands </aff><aff id="Aff9"><label/>Wenckebach Institute, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands </aff><aff id="Aff10"><label/>Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, P.O. Box 85500, 3508 GA Utrecht, The Netherlands </aff></contrib-group><pub-date pub-type="epub"><day>14</day><month>2</month><year>2015</year></pub-date><pub-date pub-type="pmc-release"><day>14</day><month>2</month><year>2015</year></pub-date><pub-date pub-type="ppub"><year>2015</year></pub-date><volume>23</volume><issue>9</issue><fpage>2623</fpage><lpage>2631</lpage><history><date date-type="received"><day>5</day><month>9</month><year>2014</year></date><date date-type="accepted"><day>22</day><month>1</month><year>2015</year></date></history><permissions><copyright-statement>&#x000a9; The Author(s) 2015</copyright-statement><license license-type="OpenAccess"><license-p>
<bold>Open Access</bold> This article is distributed under the terms of the Creative Commons Attribution Noncommercial License which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and the source are credited.</license-p></license></permissions><abstract id="Abs1"><sec><title>Purpose</title><p>This study explored demographic, clinical, and psychological moderators of the effect of a group-based physical exercise intervention on global quality of life (QoL) among cancer survivors who completed treatment.</p></sec><sec><title>Methods</title><p>Cancer survivors were assigned to a 12-week physical exercise (<italic>n</italic>&#x02009;=&#x02009;147) or a wait-list control group (<italic>n</italic>&#x02009;=&#x02009;62). The main outcome measure was global QoL, assessed with the EORTC QLQ-C30 at baseline and 12&#x000a0;weeks later. Potential moderators were age, gender, education level, marital status, employment status, type of treatment, time since treatment, the presence of comorbidities, fatigue, general self-efficacy, depression, and anxiety. Linear regression analyses were used to test effect modification of the intervention by each moderator variable using interaction tests (<italic>p</italic>&#x02009;&#x02264;&#x02009;0.10).</p></sec><sec><title>Results</title><p>The physical exercise intervention effect on global QoL was larger for cancer survivors who received radiotherapy (&#x003b2;&#x02009;=&#x02009;10.3, 95&#x000a0;% confidence interval (CI)&#x02009;=&#x02009;4.4; 16.2) than for cancer survivors who did not receive radiotherapy (&#x003b2;&#x02009;=&#x02009;1.8, 95&#x000a0;% CI&#x02009;=&#x02009;&#x02212;5.9; 9.5, <italic>p</italic><sub>interaction</sub>&#x02009;=&#x02009;0.10), larger for cancer survivors who received a combination of chemoradiotherapy (&#x003b2;&#x02009;=&#x02009;13.0, 95&#x000a0;% CI&#x02009;=&#x02009;6.0; 20.1) than for those who did not receive this combination of treatments (&#x003b2;&#x02009;=&#x02009;2.5, 95&#x000a0;% CI&#x02009;=&#x02009;&#x02212;3.7; 8.7, <italic>p</italic><sub>interaction</sub>&#x02009;=&#x02009;0.02), and larger for cancer survivors with higher baseline levels of fatigue (&#x003b2;&#x02009;=&#x02009;12.6, 95&#x000a0;% CI&#x02009;=&#x02009;5.7; 19.6) than for those with lower levels (&#x003b2;&#x02009;=&#x02009;2.4, 95&#x000a0;% CI&#x02009;=&#x02009;&#x02212;3.9; 8.7, <italic>p</italic><sub>interaction</sub>&#x02009;=&#x02009;0.03). No other moderating effects were found.</p></sec><sec><title>Conclusions</title><p>This study suggests that cancer treatment modality and baseline fatigue levels moderate the effect of a physical exercise program on cancer survivors&#x02019;global QoL.</p></sec></abstract><kwd-group xml:lang="en"><title>Keywords</title><kwd>Cancer</kwd><kwd>Physical exercise</kwd><kwd>Fatigue</kwd><kwd>Quality of life</kwd><kwd>Treatment modality</kwd></kwd-group><custom-meta-group><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#x000a9; Springer-Verlag Berlin Heidelberg 2015</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="Sec1" sec-type="introduction"><title>Introduction</title><p>Due to advances in detection and treatment of cancer, the number of cancer survivors in Western countries has increased substantially over the last decades and is expected to rise in the years to come [<xref ref-type="bibr" rid="CR1">1</xref>]. In Europe, the 5-year cancer survival rate has increased from 8 million in 2002 to 9.8 million in 2012 [<xref ref-type="bibr" rid="CR2">2</xref>, <xref ref-type="bibr" rid="CR3">3</xref>]. Despite increased survival rates, however, many cancer survivors experience physical and psychological problems related to the disease and its treatment, such as increased fatigue, anxiety, depression, and decreased physical fitness and function [<xref ref-type="bibr" rid="CR4">4</xref>]. These problems negatively affect the cancer survivors&#x02019; quality of life (QoL) [<xref ref-type="bibr" rid="CR5">5</xref>].</p><p>Several meta-analyses have shown that physical exercise may improve their QoL, but reported effect sizes were small to moderate (range 0.29&#x02013;0.48) [<xref ref-type="bibr" rid="CR6">6</xref>&#x02013;<xref ref-type="bibr" rid="CR9">9</xref>]. In a physical exercise study performed in the Netherlands, we found a moderate effect (Cohen&#x02019;s d&#x02009;=&#x02009;0.51) of a 12-week group-based physical exercise program on global QoL of cancer survivors who completed cancer treatment compared to a wait-list control group (WLC). In addition, 53&#x000a0;% of cancer survivors who completed the program had a clinically relevant improvement (&#x0003e;10 points) in global QoL [<xref ref-type="bibr" rid="CR10">10</xref>].</p><p>One possible explanation for the small to moderate effect sizes is that these interventions were offered to a heterogeneous group of cancer survivors and were not sufficiently targeted to the specific populationswith highest needs [<xref ref-type="bibr" rid="CR11">11</xref>]. It is therefore important to investigate which subgroups of survivors are most likely to benefit from a physical exercise program. Insight into these moderators will help to determine which specific survivor group should be referred to the physical exercise program [<xref ref-type="bibr" rid="CR12">12</xref>].</p><p>In previous studies among survivors undergoing treatment for breast cancer [<xref ref-type="bibr" rid="CR13">13</xref>] and lymphoma [<xref ref-type="bibr" rid="CR14">14</xref>], Courneya and colleagues showed that demographic and clinical variables, baseline health, and psychological function may moderate the physical exercise effects on QoL. Aerobic exercise had larger effects on QoL in survivors with breast cancer who were not married compared to those who were [<xref ref-type="bibr" rid="CR13">13</xref>]. Compared to their counterparts, resistance exercise effects were larger for breast cancer survivors who were not married and had a preference for resistance exercises [<xref ref-type="bibr" rid="CR13">13</xref>]. In cancer survivors with lymphoma, greater benefits of aerobic exercise on QoL were found in cancer survivors who were unmarried, had normal weight or were obese, or were in poor/fair health compared to cancer survivors who were married, overweight (but not obese), and in good health, respectively [<xref ref-type="bibr" rid="CR14">14</xref>].</p><p>The current analyses used data from our previous trial that evaluated the effects of a 12-week group-based physical exercise program among cancer survivors who completed cancer treatment [<xref ref-type="bibr" rid="CR10">10</xref>, <xref ref-type="bibr" rid="CR15">15</xref>, <xref ref-type="bibr" rid="CR16">16</xref>]. The aim of the present analyses was to explore which demographic (age, gender, education level, marital status, and employment status), clinical (type of treatment, time since treatment, presence of comorbidity), and psychological (fatigue, self-efficacy, symptoms of depression and anxiety) characteristics moderated the physical exercise effects on cancer survivors&#x02019; global QoL.</p></sec><sec id="Sec2" sec-type="materials|methods"><title>Materials and methods</title><sec id="Sec3"><title>Recruitment and allocation</title><p>This study is part of a multicenter randomized controlled trial evaluating the effects of group-based physical exercise on cancer survivors&#x02019; QoL [<xref ref-type="bibr" rid="CR10">10</xref>, <xref ref-type="bibr" rid="CR15">15</xref>, <xref ref-type="bibr" rid="CR16">16</xref>]. Detailed descriptions of the study procedures are published elsewhere [<xref ref-type="bibr" rid="CR10">10</xref>, <xref ref-type="bibr" rid="CR15">15</xref>, <xref ref-type="bibr" rid="CR16">16</xref>]. The trial was conducted at four rehabilitation or medical centers in the Netherlands [<xref ref-type="bibr" rid="CR10">10</xref>, <xref ref-type="bibr" rid="CR15">15</xref>, <xref ref-type="bibr" rid="CR16">16</xref>]. The medical ethics committees of the University Medical Center Utrecht and the local centers approved the study.</p><p>Participants aged &#x02265;18&#x000a0;years, who had completed cancer treatment at least 3&#x000a0;months before study entry and had an estimated life expectancy &#x02265;1&#x000a0;year were recruited between February 2004 and December 2005. After a written consent, these cancer survivors completed baseline measurements and were randomized to physical training (PT) or PT plus cognitive behavioral therapy (PT + CBT). Randomization was conducted at group level by an independent researcher using a randomization list. Consecutive groups of 8 to 12 subjects were randomly assigned to each group. Both interventions were balanced in each center [<xref ref-type="bibr" rid="CR10">10</xref>, <xref ref-type="bibr" rid="CR15">15</xref>, <xref ref-type="bibr" rid="CR16">16</xref>]. Eligible cancer survivors were invited to participate in the WLC group if, because of fully booked rehabilitation groups, they had to wait at least 3&#x000a0;months to start with a 12-week group-based multidisciplinary cancer rehabilitation program in other Dutch centers than the four recruiting centers [<xref ref-type="bibr" rid="CR10">10</xref>, <xref ref-type="bibr" rid="CR15">15</xref>, <xref ref-type="bibr" rid="CR16">16</xref>].</p><p>In total, 209 cancer survivors participated in the study; 71 were allocated to PT, 76 to PT + CBT, and 62 to WLC. Measurements were performed at baseline and after 12&#x000a0;weeks. Participants&#x02019; adherence rates were 84&#x000a0;% of the total number of 24 PT sessions and 82&#x000a0;% of 12 CBT sessions. In total, 196 (94&#x000a0;%) cancer survivors completed the postintervention assessment [<xref ref-type="bibr" rid="CR15">15</xref>]. No differences in changes from preintervention to postintervention in physical fitness, fatigue, distress, and QoL were found between PT and PT + CBT groups [<xref ref-type="bibr" rid="CR10">10</xref>, <xref ref-type="bibr" rid="CR15">15</xref>, <xref ref-type="bibr" rid="CR16">16</xref>]. In the present study, we therefore combined the two intervention groups into one group. Because differences in moderating effects between the intervention groups may be present, we conducted a sensitivity analyses in which we separately examined moderation effects.</p></sec><sec id="Sec4"><title>Interventions</title><p>Detailed descriptions of PT and CBT are provided elsewhere [<xref ref-type="bibr" rid="CR16">16</xref>, <xref ref-type="bibr" rid="CR17">17</xref>]. PT was supervised by two physical therapists and CBT by a psychologist and a social worker, all experienced professionals in cancer rehabilitation. PT took place two times per week, for 12&#x000a0;weeks, in groups of 8&#x02013;12 cancer survivors and included individual aerobic training (20&#x02013;30&#x000a0;min), muscle strength training (20&#x02013;30&#x000a0;min), and group sports (60&#x000a0;min). Intensity of the individual aerobic training was based on the maximum heart rate determined during baseline symptom-limited ergometry and the Karvonen formula. Exercise training was performed at a heart rate of [heart rate at rest + 40&#x02013;50&#x000a0;% of (peak heart rate &#x02212; heart rate at rest)] during the first 4&#x000a0;weeks and gradually increased to a heart rate of [heart rate at rest + 70&#x02013;80&#x000a0;% of (peak heart rate &#x02212; heart rate at rest)] in week 12.</p><p>Intensity of the muscle strength training was based on baseline individual 1 &#x02212; repetition maximum (1-RM). Training intensity started at 30&#x000a0;% of the 1-RM during the first week and increased to 50&#x02013;60&#x000a0;% of 1-RM in week 12. Group sports were included to promote enjoyment and adoption of a physically active lifestyle. Cancer survivors also received information about the benefits of exercise and, depending on their individual goals, also on coping with fatigue, restoration of the balance between demand and capacity during tasks and activities, exercise physiology, illness perceptions, and self-management to support them in regulating their physical activity.</p><p>The interventions were based on the principles of group-based self-management, i.e., goal selection, information collection, information processing and evaluation, decision making, action, and self-reaction [<xref ref-type="bibr" rid="CR18">18</xref>]. These principles were incorporated by setting and monitoring personal training goals, and monitoring training progress using exercise logs, heart rate monitors, and the Borg Scale for dyspnea and fatigue. Self-efficacy improvement strategies included encouraging mastery experiences by starting at low intensity, improvements in physiological arousal by improving exercise capacity, verbal persuasion to perform training activities, and enhancing vicarious learning through the group format delivery [<xref ref-type="bibr" rid="CR19">19</xref>].</p><p>CBT was conducted once a week for 12&#x000a0;weeks, in 2-h group sessions and aimed to train self-management skills using a cognitive behavioral problem-solving approach [<xref ref-type="bibr" rid="CR20">20</xref>]. This approach aimed at finding effective and adaptive solutions to stressful problems and at changing dysfunctional cognition, emotions, and behaviors [<xref ref-type="bibr" rid="CR21">21</xref>]. It included discussions on distress, exercise physiology, relaxation (sessions 1 to 4), and training self-management skills to realize personal goals (sessions 5 to 12). During this process, also problem orientation, problem definition and formulation and goal setting, generation of alternative solutions (brainstorming), decision making, and solution implementation and verification were discussed.</p></sec><sec id="Sec5"><title>Measures and measurements</title><sec id="Sec6"><title>Outcome</title><p><italic>Global QoL</italic> was assessed at baseline and 12&#x000a0;weeks later using the subscale of the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire C30 (EORTC QLQ-C30) [<xref ref-type="bibr" rid="CR22">22</xref>]. The EORTC QLQ-C30 is a reliable and valid instrument that has been used in many studies evaluating effects of clinical and psychosocial interventions on cancer survivors&#x02019; HRQoL [<xref ref-type="bibr" rid="CR22">22</xref>]. The global QoL subscale includes two questions addressing perceptions of general health and overall QoL. After applying a linear transformation procedure according to the manual, the scores of the scale range from 0 to 100, with higher scores representing a higher global QoL.</p></sec></sec><sec id="Sec7"><title>Potential moderators</title><sec id="Sec8"><title>Demographic and clinical characteristics</title><p>Demographic characteristics including age, gender, education level, marital status, and employment status were collected at baseline using a self-reported questionnaire. We dichotomized education level into low (elementary and lower vocational education) versus middle and high (secondary and secondary vocational education, higher vocational and university education), marital status into single versus married and/or living together, and employment into employed versus unemployed at diagnosis. Because differences in moderating effects may appear when education level is dichotomized into low and middle versus high, we conducted a sensitivity analyses in which we examined this latter combination.</p><p>Clinical characteristics were collected using a self-report questionnaire including type of cancer, type of treatment received, time since completion of treatment, cancer recurrence, and presence of comorbidity. We dichotomized the treatment regimens surgery, radiotherapy, and chemotherapy into received versus not received. In addition, we dichotomized treatment regimens into having received both chemotherapy and radiotherapy versus one of the two or none. Disease recurrence was dichotomized into no or unknown versus yes and presence of comorbidity into none versus any. Cancer survivors with comorbidity reported to receive medical treatment for one or more of the following problems: cardiac problems, vascular problems, diabetes, asthma, rheumatic problems, musculoskeletal problems, psychological problems, or other complaints. Clinical characteristics were confirmed by the referring physicians.</p></sec><sec id="Sec9"><title>Psychological characteristics</title><sec id="FPar1"><title>General fatigue</title><p>General fatigue was assessed at baseline with the four-item general fatigue subscale of the multidimensional fatigue inventory (MFI) [<xref ref-type="bibr" rid="CR23">23</xref>]. The total MFI consists of 20 statements for which a person indicates the extent to which, during the previous few days, a particular statement applies to him or her on a five-point scale. The possible range for the general fatigue subscale is 4&#x02013;20, with higher scores indicating higher levels of fatigue. The MFI has good internal consistency (average Cronbach&#x02019;s alpha&#x02009;=&#x02009;0.84) [<xref ref-type="bibr" rid="CR23">23</xref>].</p></sec><sec id="FPar2"><title>General self-efficacy</title><p>General self-efficacy was measured at baseline with the standardized Dutch version of the general self-efficacy scale [<xref ref-type="bibr" rid="CR24">24</xref>]. This 16-item questionnaire yields a total score and three subscales: willingness to expend effort in completing a behavior, persistence in the face of adversity, and willingness to initiate behavior. The total score, with a possible range from 16 to 80, was used for further analysis with higher scores representing higher self-efficacy.</p></sec><sec id="FPar3"><title>Anxiety and depression</title><p>Anxiety and depression were assessed at baseline with the 14-item Hospital Anxiety and Depression Scale (HADS) [<xref ref-type="bibr" rid="CR25">25</xref>], validated for the Dutch population [<xref ref-type="bibr" rid="CR26">26</xref>] and cancer survivors [<xref ref-type="bibr" rid="CR27">27</xref>]. The HADS contains an anxiety and a depression subscale, both ranging from 0 to 21 points. A score &#x02265;8 on the subscale was used to indicate possible anxiety or depression [<xref ref-type="bibr" rid="CR28">28</xref>].</p></sec></sec></sec><sec id="Sec10"><title>Statistical analysis</title><p>Baseline characteristics are presented as means and standard deviations (SD) or as numbers and percentages. Moderation analyses were conducted according to procedures proposed by Aguinis et al. [<xref ref-type="bibr" rid="CR29">29</xref>]. First, we tested the underlying assumption of homoscedasticity among the moderator categories, indicating that the residual variances (i.e., the error variances that remain after predicting a dependent variable from the independent variables) are constant across the moderator categories. To test this assumption, we used the computer program ALTMMR. This program provides four tests: Deshon and Alexander&#x02019;s rule for homogeneity, Bartlett&#x02019;s test, James&#x02019;s test, and Alexander&#x02019;s test [<xref ref-type="bibr" rid="CR30">30</xref>&#x02013;<xref ref-type="bibr" rid="CR33">33</xref>]. Homoscedasticity was assumed if three or more tests indicated homogeneous residual variances [<xref ref-type="bibr" rid="CR29">29</xref>].</p><p>Second, we examined the achieved power for each moderator and the sample sizes required to be able to conduct subgroup analysis with a power of 80&#x000a0;%. For categorical moderators, we used the POWER computer program developed by Aguinis et al. [<xref ref-type="bibr" rid="CR34">34</xref>]. For continuous moderators, we used the computer program GPower developed by Faul et al. [<xref ref-type="bibr" rid="CR35">35</xref>].</p><p>Third, we used linear regression analysis to test effect modification of the intervention by each moderator variable in the form of an interaction test [<xref ref-type="bibr" rid="CR36">36</xref>]. Global QoL was modeled to compare changes over time across intervention moderator groups. The analyses were adjusted for the baseline value of the outcome, marital status, educational level, and disease recurrence. The latter three variables were included because they differ significantly between the intervention and control group [<xref ref-type="bibr" rid="CR10">10</xref>, <xref ref-type="bibr" rid="CR15">15</xref>, <xref ref-type="bibr" rid="CR16">16</xref>]. If homoscedasticity was not assumed, we used weighted least squares regression analyses. In this analysis, a weight factor was added in the analysis to adjust the residual error variance of the model [<xref ref-type="bibr" rid="CR36">36</xref>]. The weighted factor was calculated for each moderator group by the number of degrees of freedom of the residual variation divided by the sum of squares of the residual variation.</p><p>We conducted stratified analysis to examine the intervention effect in the different moderator categories. In case of a continuous moderator, conditional effect of the intervention on global QoL after the exercise intervention was examined for the &#x02212;1SD, mean, and +1SD values. A variable was considered a potential moderator when the <italic>p</italic> value of the interaction term was &#x02264;0.10. To examine whether a significant moderating effect could be explained by differences in intervention adherence, we compared differences in adherence between moderator subgroups with an independent samples&#x02019; <italic>t</italic> test.</p><p>Finally, we calculated Cohen&#x02019;s <italic>f</italic><sup>2</sup> effect sizes [<xref ref-type="bibr" rid="CR37">37</xref>] providing an estimate of the variance explained by the interaction term [<xref ref-type="bibr" rid="CR37">37</xref>]. In case of continuous moderators or homoscedasticity in categorical moderators, effect sizes were calculated by <italic>f</italic><sup>2</sup>&#x02009;=&#x02009;<italic>R</italic><sub>2</sub><sup>2</sup>&#x02009;&#x02212;&#x02009;<italic>R</italic><sub>1</sub><sup>2</sup>, where <italic>R</italic><sub>2</sub><sup>2</sup> is the proportion of variance accounted for with all variables in the model (including the interaction term), and <italic>R</italic><sub>1</sub><sup>2</sup> is the proportion of variance accounted for with all variables without the interaction term in the model. In case of heteroscedasticity in categorical moderators, effect sizes were calculated by <italic>f</italic><sup>2</sup>&#x02009;=&#x02009;<italic>R</italic><sub>2</sub><sup>2</sup>&#x02009;&#x02212;&#x02009;<italic>R</italic><sub>1</sub><sup>2</sup>&#x02009;/&#x02009;1&#x02009;&#x02212;&#x02009;<italic>R</italic><sub>2</sub><sup>2</sup>. We used Cohen&#x02019;s cutoff points for multiple regression modeling of <italic>f</italic><sup>2</sup>&#x02009;=&#x02009;0.02, <italic>f</italic><sup>2</sup>&#x02009;=&#x02009;0.15, and <italic>f</italic><sup>2</sup>&#x02009;=&#x02009;0.35 to indicate a small, medium, or large effect, respectively [<xref ref-type="bibr" rid="CR37">37</xref>].</p><p>We used SPSS 20.0 (IBM Corp. Released 2011. IBM SPSS Statistics for Windows, version 20.0. Armonk, NY: IBM Corp.) to conduct the analyses.</p></sec></sec><sec id="Sec11" sec-type="results"><title>Results</title><p>The mean age of cancer survivors in the exercise group was 48.8&#x000a0;years (SD&#x02009;=&#x02009;10.9), 84&#x000a0;% were female and 56&#x000a0;% were diagnosed with breast cancer (Table&#x000a0;<xref rid="Tab1" ref-type="table">1</xref>). Cancer survivors in the WLC group were on average 51.3&#x000a0;years old (SD&#x02009;=&#x02009;8.8), 90&#x000a0;% were female and 61&#x000a0;% were diagnosed with breast cancer.<table-wrap id="Tab1"><label>Table 1</label><caption><p>Distribution of potential moderators by group assignment</p></caption><table frame="hsides" rules="groups"><thead><tr><th>Variable</th><th>Physical exercise group (<italic>n</italic>&#x02009;=&#x02009;147)</th><th>Wait-list control group (<italic>n</italic>&#x02009;=&#x02009;62)</th></tr></thead><tbody><tr><td colspan="3">Demographic</td></tr><tr><td>&#x02003;Age, mean (SD) years</td><td>48.8 (10.9)</td><td>51.3 (8.8)</td></tr><tr><td colspan="3">&#x02003;Gender, <italic>n</italic> (%)</td></tr><tr><td>&#x02003;&#x02003;Male</td><td>24 (16)</td><td>6 (10)</td></tr><tr><td>&#x02003;&#x02003;Female</td><td>123 (84)</td><td>56 (90)</td></tr><tr><td colspan="3">&#x02003;Education level, <italic>n</italic> (%)*</td></tr><tr><td>&#x02003;&#x02003;Low</td><td>20 (14)</td><td>16 (26)</td></tr><tr><td>&#x02003;&#x02003;Middle</td><td>72 (49)</td><td>32 (52)</td></tr><tr><td>&#x02003;&#x02003;High</td><td>55 (37)</td><td>14 (22)</td></tr><tr><td colspan="3">&#x02003;Marital status, <italic>n</italic> (%)*</td></tr><tr><td>&#x02003;&#x02003;Single</td><td>43 (29)</td><td>7 (11)</td></tr><tr><td>&#x02003;&#x02003;Married</td><td>104 (71)</td><td>55 (89)</td></tr><tr><td colspan="3">&#x02003;Employment status, <italic>n</italic> (%)</td></tr><tr><td>&#x02003;&#x02003;Not employed at diagnosis</td><td>40 (28)</td><td>16 (26)</td></tr><tr><td>&#x02003;&#x02003;Employed at diagnosis</td><td>107 (73)</td><td>46 (74)</td></tr><tr><td colspan="3">Clinical</td></tr><tr><td colspan="3">&#x02003;Type of cancer, <italic>n</italic> (%)</td></tr><tr><td>&#x02003;&#x02003;Breast</td><td>82 (56)</td><td>38 (61)</td></tr><tr><td>&#x02003;&#x02003;Hematological</td><td>23 (16)</td><td>10 (16)</td></tr><tr><td>&#x02003;&#x02003;Gynecological</td><td>18 (12)</td><td>7 (11)</td></tr><tr><td>&#x02003;&#x02003;Urologic</td><td>9 (6)</td><td>0 (0)</td></tr><tr><td>&#x02003;&#x02003;Lung</td><td>4 (3)</td><td>4 (7)</td></tr><tr><td>&#x02003;&#x02003;Colon</td><td>3 (2)</td><td>2 (3)</td></tr><tr><td>&#x02003;&#x02003;Other</td><td>8 (5)</td><td>1 (2)</td></tr><tr><td colspan="3">&#x02003;Radiotherapy, <italic>n</italic> (%)</td></tr><tr><td>&#x02003;&#x02003;No</td><td>63 (43)</td><td>23 (37)</td></tr><tr><td>&#x02003;&#x02003;Yes</td><td>84 (57)</td><td>39 (63)</td></tr><tr><td colspan="3">&#x02003;Chemotherapy, <italic>n</italic> (%)</td></tr><tr><td>&#x02003;&#x02003;No</td><td>47 (32)</td><td>21 (34)</td></tr><tr><td>&#x02003;&#x02003;Yes</td><td>100 (68)</td><td>41 (66)</td></tr><tr><td colspan="3">&#x02003;Radiotherapy and chemotherapy, <italic>n</italic> (%)</td></tr><tr><td>&#x02003;&#x02003;No</td><td>87 (59)</td><td>35 (56)</td></tr><tr><td>&#x02003;&#x02003;Yes</td><td>60 (41)</td><td>27 (44)</td></tr><tr><td>&#x02003;Time since treatment, mean (SD) years</td><td>1.3 (1.7)</td><td>1.9 (2.7)</td></tr><tr><td colspan="3">&#x02003;Recurrence &#x0003e;3&#x000a0;months ago*</td></tr><tr><td>&#x02003;&#x02003;No</td><td>133 (90)</td><td>47 (76)</td></tr><tr><td>&#x02003;&#x02003;Yes</td><td>14 (10)</td><td>15 (24)</td></tr><tr><td colspan="3">&#x02003;Presence of comorbidity, <italic>n</italic> (%)</td></tr><tr><td>&#x02003;&#x02003;No comorbidity</td><td>79 (54)</td><td>34 (55)</td></tr><tr><td>&#x02003;&#x02003;Comorbidity</td><td>68 (46)</td><td>27 (43)</td></tr><tr><td colspan="3">Psychological</td></tr><tr><td>&#x02003;General fatigue (MFI), mean (SD)</td><td>15.6 (3.4)</td><td>15.0 (3.3)</td></tr><tr><td>&#x02003;General self-efficacy (ALCOS), mean (SD)</td><td>44.0 (8.8)</td><td>42.6 (8.5)</td></tr><tr><td colspan="3">&#x02003;Depression (HADS), <italic>n</italic> (%)</td></tr><tr><td>&#x02003;&#x02003;No (&#x0003c;8)</td><td>104 (71)</td><td>35 (57)</td></tr><tr><td>&#x02003;&#x02003;Yes &#x02265;8)</td><td>43 (29)</td><td>27 (43)</td></tr><tr><td colspan="3">&#x02003;Anxiety (HADS), <italic>n</italic> (%)</td></tr><tr><td>&#x02003;&#x02003;No (&#x0003c;8)</td><td>77 (52)</td><td>34 (55)</td></tr><tr><td>&#x02003;&#x02003;Yes (&#x02265;8)</td><td>70 (48)</td><td>28 (45)</td></tr><tr><td>&#x02003;Global QoL (EORTC QLQ-C30), mean (SD)</td><td>57.1 (17.6)</td><td>60.1 (18.4)</td></tr></tbody></table><table-wrap-foot><p>
<italic>ALCOS</italic> general self-efficacy scale, <italic>CT</italic> chemotherapy, <italic>EORTC QLQ-C30</italic> European Organization for Research and Treatment of Cancer Quality of Life Questionnaire, <italic>HADS</italic> Hospital Anxiety and Depression Scale, <italic>MFI</italic> multidimensional fatigue inventory, <italic>RT</italic> radiotherapy, <italic>QoL</italic> quality of life, <italic>SD</italic> standard deviation</p><p>*<italic>p</italic>&#x02009;&#x0003c;&#x02009;0.05, significant differences between exercise and wait-list control groups using chi-squared tests</p></table-wrap-foot></table-wrap></p><p>Homoscedasticity was found for gender, marital status, employment status, presence of comorbidity, and anxiety (Table&#x000a0;<xref rid="Tab2" ref-type="table">2</xref>). Heteroscedasticity was found for education level, radiotherapy, chemotherapy, combination chemoradiotherapy, and depression. The achieved power for the categorical variables varied between 0.2&#x000a0;% for marital status and 54&#x000a0;% for combination chemoradiotherapy (Table&#x000a0;<xref rid="Tab2" ref-type="table">2</xref>).<table-wrap id="Tab2"><label>Table 2</label><caption><p>Exercise intervention effects on global quality of life (QoL), stratified by potential moderator subgroups</p></caption><table frame="hsides" rules="groups"><thead><tr><th/><th/><th colspan="2">Intervention effect on global QoL</th><th/><th/><th/></tr><tr><th>Moderator</th><th>Number</th><th>&#x003b2; (95&#x000a0;% CI)<sup>b</sup>
</th><th>
<italic>p</italic>
<sub>interaction</sub>
<sup>b</sup>
</th><th>
<italic>f</italic>
<sup>2</sup>
</th><th>ESP</th><th>
<italic>n</italic> (P<sub>80&#x000a0;%</sub>)</th></tr></thead><tbody><tr><td colspan="7">Demographic</td></tr><tr><td>&#x02003;Age, years</td><td char="." align="char">196</td><td/><td char="." align="char">0.13</td><td char="." align="char">0.01</td><td char="." align="char">0.29</td><td char="." align="char">787</td></tr><tr><td>&#x02003;&#x02003;&#x02212;1SD (39.4)</td><td/><td>11.0 (3.7; 18.3)</td><td/><td/><td/><td/></tr><tr><td>&#x02003;&#x02003;Mean (49.7 )</td><td/><td>7.1 (2.3; 11.9)</td><td/><td/><td/><td/></tr><tr><td>&#x02003;&#x02003;+1SD (60.0)</td><td/><td>3.2 (&#x02212;3.4; 9.8)</td><td/><td/><td/><td/></tr><tr><td>&#x02003;Gender<sup>a</sup>
</td><td/><td/><td char="." align="char">0.73</td><td char="." align="char">0.001</td><td char="." align="char">0.16</td><td/></tr><tr><td>&#x02003;&#x02003;Male</td><td char="." align="char">28</td><td>8.9 (&#x02212;4.9; 22.6)</td><td/><td/><td/><td char="." align="char">154</td></tr><tr><td>&#x02003;&#x02003;Female</td><td char="." align="char">168</td><td>6.3 (1.2; 11.4)</td><td/><td/><td/><td char="." align="char">924</td></tr><tr><td>&#x02003;Education level<sup>a</sup>
</td><td/><td/><td char="." align="char">0.78</td><td char="." align="char">0.0003</td><td char="." align="char">0.03</td><td/></tr><tr><td>&#x02003;&#x02003;Low</td><td char="." align="char">34</td><td>8.2 (&#x02212;2.0; 18.5)</td><td/><td/><td/><td char="." align="char">374</td></tr><tr><td>&#x02003;&#x02003;Middle or high</td><td char="." align="char">162</td><td>6.7 (1.3; 12.0)</td><td/><td/><td/><td char="." align="char">1782</td></tr><tr><td>&#x02003;Marital status<sup>a</sup>
</td><td/><td/><td char="." align="char">0.56</td><td char="." align="char">0.001</td><td char="." align="char">0.02</td><td/></tr><tr><td>&#x02003;&#x02003;Single</td><td char="." align="char">48</td><td>10.3 (&#x02212;1.9; 22.5)</td><td/><td/><td/><td char="." align="char">360</td></tr><tr><td>&#x02003;&#x02003;Married</td><td char="." align="char">148</td><td>6.4 (1.2; 11.6)</td><td/><td/><td/><td char="." align="char">1110</td></tr><tr><td>&#x02003;Employment status<sup>a</sup>
</td><td/><td/><td char="." align="char">0.50</td><td char="." align="char">0.002</td><td char="." align="char">0.12</td><td/></tr><tr><td>&#x02003;&#x02003;Not employed at diagnosis</td><td char="." align="char">52</td><td>4.50 (&#x02212;4.6; 13.6)</td><td/><td/><td/><td char="." align="char">260</td></tr><tr><td>&#x02003;&#x02003;Employed at diagnosis</td><td char="." align="char">144</td><td>8.1 (2.6; 13.6)</td><td/><td/><td/><td char="." align="char">720</td></tr><tr><td colspan="7">Clinical</td></tr><tr><td>&#x02003;Radiotherapy<sup>a</sup>
</td><td/><td/><td char="." align="char">0.10</td><td char="." align="char">0.02</td><td char="." align="char">0.23</td><td/></tr><tr><td>&#x02003;&#x02003;No</td><td char="." align="char">81</td><td>1.8 (&#x02212;5.9; 9.5)</td><td/><td/><td/><td char="." align="char">230</td></tr><tr><td>&#x02003;&#x02003;Yes</td><td char="." align="char">115</td><td>10.3 (4.4; 16.2)</td><td/><td/><td/><td char="." align="char">330</td></tr><tr><td>&#x02003;Chemotherapy<sup>a</sup>
</td><td/><td/><td char="." align="char">0.14</td><td char="." align="char">0.02</td><td char="." align="char">0.37</td><td/></tr><tr><td>&#x02003;&#x02003;No</td><td char="." align="char">62</td><td>2.0 (&#x02212;6.2; 10.1)</td><td/><td/><td/><td char="." align="char">155</td></tr><tr><td>&#x02003;&#x02003;Yes</td><td char="." align="char">134</td><td>9.8 (3.9; 15.7)</td><td/><td/><td/><td char="." align="char">335</td></tr><tr><td>&#x02003;Radiotherapy and chemotherapy</td><td/><td/><td char="." align="char">0.02</td><td char="." align="char">0.03</td><td char="." align="char">0.54</td><td/></tr><tr><td>&#x02003;&#x02003;No</td><td char="." align="char">87</td><td>2.5 (&#x02212;3.7; 8.7)</td><td/><td/><td/><td char="." align="char">180</td></tr><tr><td>&#x02003;&#x02003;Yes</td><td char="." align="char">122</td><td>13.1 (6.0; 20.1)</td><td/><td/><td/><td char="." align="char">140</td></tr><tr><td>&#x02003;Time since treatment in years</td><td char="." align="char">196</td><td/><td char="." align="char">0.14</td><td char="." align="char">0.01</td><td char="." align="char">0.29</td><td char="." align="char">787</td></tr><tr><td>&#x02003;&#x02003;&#x02212;1SD (0.1 )</td><td/><td>4.8 (&#x02212;0.8; 10.5)</td><td/><td/><td/><td/></tr><tr><td>&#x02003;&#x02003;Mean (1.5)</td><td/><td>6.9 (2.1; 11.7)</td><td/><td/><td/><td/></tr><tr><td>&#x02003;&#x02003;+1SD (3.6)</td><td/><td>10.1 (3.8; 16.4)</td><td/><td/><td/><td/></tr><tr><td>&#x02003;Presence of comorbidity<sup>a</sup>
</td><td/><td/><td char="." align="char">0.88</td><td char="." align="char">0.0001</td><td char="." align="char">0.15</td><td/></tr><tr><td>&#x02003;&#x02003;No comorbidity</td><td char="." align="char">102</td><td>6.7 (0.2; 13.1)</td><td/><td/><td/><td char="." align="char">273</td></tr><tr><td>&#x02003;&#x02003;Comorbidity</td><td char="." align="char">93</td><td>7.4 (0.4; 14.4)</td><td/><td/><td/><td char="." align="char">253</td></tr><tr><td colspan="7">Psychological</td></tr><tr><td>&#x02003;General fatigue</td><td char="." align="char">196</td><td/><td char="." align="char">0.03</td><td char="." align="char">0.02</td><td char="." align="char">0.50</td><td char="." align="char">395</td></tr><tr><td>&#x02003;&#x02003;&#x02212;1SD (12.1)</td><td/><td>2.4 (&#x02212;3.9; 8.7)</td><td/><td/><td/><td/></tr><tr><td>&#x02003;&#x02003;Mean (15.4)</td><td/><td>7.5 (2.7; 12.3)</td><td/><td/><td/><td/></tr><tr><td>&#x02003;&#x02003;+1SD (18.8)</td><td/><td>12.7 (5.7; 19.6)</td><td/><td/><td/><td/></tr><tr><td>&#x02003;General self-efficacy</td><td char="." align="char">196</td><td/><td char="." align="char">0.20</td><td char="." align="char">0.01</td><td char="." align="char">0.29</td><td char="." align="char">787</td></tr><tr><td>&#x02003;&#x02003;&#x02212;1SD (35.1)</td><td/><td>9.9 (3.1; 16.6)</td><td/><td/><td/><td/></tr><tr><td>&#x02003;&#x02003;Mean (43.9)</td><td/><td>6.7 (1.9; 11.5)</td><td/><td/><td/><td/></tr><tr><td>&#x02003;&#x02003;+1SD (52.6)</td><td/><td>3.6 (&#x02212;3.2; 10.4)</td><td/><td/><td/><td/></tr><tr><td>&#x02003;Depression</td><td/><td/><td char="." align="char">0.67</td><td char="." align="char">0.002</td><td char="." align="char">0.30</td><td/></tr><tr><td>&#x02003;&#x02003;No (&#x0003c;8)</td><td char="." align="char">131</td><td>5.9 (&#x02212;0.3; 12.0)</td><td/><td/><td/><td char="." align="char">262</td></tr><tr><td>&#x02003;&#x02003;Yes (&#x02265;8)</td><td char="." align="char">65</td><td>8.0 (0.4; 15.6)</td><td/><td/><td/><td char="." align="char">130</td></tr><tr><td>&#x02003;Anxiety<sup>a</sup>
</td><td/><td/><td char="." align="char">0.64</td><td char="." align="char">0.001</td><td char="." align="char">0.22</td><td/></tr><tr><td>&#x02003;&#x02003;No (&#x0003c;8)</td><td char="." align="char">105</td><td>6.0 (&#x02212;0.3; 12.3)</td><td/><td/><td/><td char="." align="char">258</td></tr><tr><td>&#x02003;&#x02003;Yes (&#x02265;8)</td><td char="." align="char">91</td><td>8.3 (1.1; 15.5)</td><td/><td/><td/><td char="." align="char">223</td></tr></tbody></table><table-wrap-foot><p>Regression coefficients (&#x003b2;), 95&#x000a0;% confidence intervals (CI), and <italic>p</italic> value of the interaction test (p<sub>interaction</sub>) are presented as well as Cohen&#x02019;s effect size (<italic>f</italic>
<sup>2</sup>) and estimated statistical power (ESP) for the interaction effect, and the number of cancer survivors needed for estimated statistical power of 80&#x000a0;% (<italic>n</italic> (p<sub>80&#x000a0;%</sub>))</p><p>
<italic>SD</italic> standard deviation</p><p>
<sup>a</sup>No violation of homogeneity of error variances was assumed</p><p>
<sup>b</sup>Adjusted for marital status, education level, disease recurrence, and global quality of life measured at baseline</p></table-wrap-foot></table-wrap></p><p>We found a small (<italic>f</italic><sup>2</sup>&#x02009;=&#x02009;0.02, <italic>p</italic><sub>interaction</sub>&#x02009;=&#x02009;0.10) interaction effect of radiotherapy, indicating that the exercise intervention effect on global QoL was larger for cancer survivors who received radiotherapy (&#x003b2;&#x02009;=&#x02009;10.3, 95&#x000a0;% confidence interval (CI)&#x02009;=&#x02009;4.4; 16.2) than for those who did not (&#x003b2;&#x02009;=&#x02009;1.8, 95&#x000a0;% CI&#x02009;=&#x02009;&#x02212;5.9; 9.5). No statistical significant (<italic>p</italic>&#x02009;=&#x02009;0.14) moderating effect was found for chemotherapy. However, sensitivity analyses showed a significant (<italic>p</italic>&#x02009;=&#x02009;0.02) moderating effect of chemotherapy for cancer survivors in the PT + CBT group (&#x003b2;&#x02009;=&#x02009;10.1, 95&#x000a0;% CI&#x02009;=&#x02009;3.5; 16.8), but not for survivors in the PT group (&#x003b2;&#x02009;=&#x02009;9.3, 95&#x000a0;% CI&#x02009;=&#x02009;2.2; 16.3, <italic>p</italic>&#x02009;=&#x02009;0.71). Comparing cancer survivors who received a combination of chemoradiotherapy and those who received one or none of these treatments, we found a significant interaction effect (<italic>p</italic><sub>interaction</sub>&#x02009;=&#x02009;0.02) in favor of cancer survivors who received a combination of chemoradiotherapy (&#x003b2;&#x02009;=&#x02009;13.1, 95&#x000a0;% CI&#x02009;=&#x02009;6.0; 20.1) than for those who did not (&#x003b2;&#x02009;=&#x02009;2.5, 95&#x000a0;% CI&#x02009;=&#x02009;&#x02212;3.7; 8.7) (Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1</xref>). In addition, we found a small (<italic>f</italic><sup>2</sup>&#x02009;=&#x02009;0.02) but significant (<italic>p</italic><sub>interaction</sub>&#x02009;=&#x02009;0.03) interaction effect of fatigue, indicating that the exercise intervention effect on global QoL is larger for cancer survivors with higher baseline levels of fatigue (&#x003b2;&#x02009;=&#x02009;12.7, 95&#x000a0;% CI&#x02009;=&#x02009;5.7; 19.6) than for those with lower baseline fatigue levels (&#x003b2;&#x02009;=&#x02009;2.4, 95&#x000a0;% CI&#x02009;=&#x02009;&#x02212;3.9; 8.7, Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2</xref>). No differences in adherence were found for all subgroups.<fig id="Fig1"><label>Fig. 1</label><caption><p>Differences in mean global quality of life (Global QoL) post-intervention between wait-list control group (WLC) and physical exercise group (PE) according to having received a combination of chemoradiotherapy (<italic>solid line</italic>) or one or none of these treatments (<italic>dotted line</italic>)</p></caption><graphic xlink:href="520_2015_2622_Fig1_HTML" id="MO1"/></fig><fig id="Fig2"><label>Fig. 2</label><caption><p>Differences in mean global quality of life (Global QoL) post-intervention between wait-list control group (WLC) and physical exercise group (PE) according to low general fatigue (one standard deviation (SD) below the mean of general fatigue; <italic>dotted line</italic>), mean general fatigue (<italic>dashed line</italic>), and high general fatigue (one SD above the mean of general fatigue; <italic>solid line</italic>)</p></caption><graphic xlink:href="520_2015_2622_Fig2_HTML" id="MO2"/></fig></p><p>No moderating effects were found for age, gender, education level, marital status, employment status, time since treatment, presence of comorbidity, self-efficacy, depression, and anxiety (Table&#x000a0;<xref rid="Tab2" ref-type="table">2</xref>). Sensitivity analysis showed no significant moderating effect of education level when education level is dichotomized into low and medium versus high.</p></sec><sec id="Sec12" sec-type="discussion"><title>Discussion</title><p>In the current analyses, we explored moderators of physical exercise effects on global QoL. We found larger intervention effectsfor cancer survivors who received radiotherapy, and particularly for survivors who received the combination chemoradiotherapy compared to those who did not.</p><p>Cancer survivors who received the combination chemoradiotherapy improved 13 points (95&#x000a0;% CI&#x02009;=&#x02009;6; 20) on the global QoL scale, which is larger than the clinically meaningful difference of 10 points [<xref ref-type="bibr" rid="CR38">38</xref>]. In contrast, the intervention effect on global QoL was 2 points (95&#x000a0;% CI&#x02009;=&#x02009;&#x02212;6; 10) for cancer survivors who were treated with one of these treatments or none. Differences in intervention effects across moderator subgroups do not seem to be explained by exercise adherence, since no significant differences in adherence were found across moderator subgroups. A recent longitudinal study showed that cancer survivors who received both types of treatments had lower QoL and fatigue levels compared to radiotherapy or surgery alone [<xref ref-type="bibr" rid="CR39">39</xref>]. These differences in QoL may consequently give more room for improvement by physical exercise. However, we found in our study no statistically significant differences in baseline values of QoL between cancer survivors who received both radiotherapy and chemotherapy and those who received one or none of these treatments. Therefore, and due to the relatively small sample size and the exploratory nature of our analysis, our findings should be interpreted with caution. Future studies should examine whether cancer survivors who received different treatment regimens respond differently to physical exercise.</p><p>Baseline fatigue also moderated the exercise intervention effects on global QoL. Improvements in global QoL were 12 points higher in cancer survivors with high baseline levels of fatigue (&#x02265;1SD above the mean) compared to those with low baseline levels of fatigue (&#x02265;1SD below the mean), which was a clinically meaningful difference [<xref ref-type="bibr" rid="CR38">38</xref>]. Differences in effects could not be explained by differences in adherence to the intervention. It is known that higher levels of fatigue negatively affect a cancer survivors&#x02019; QoL [<xref ref-type="bibr" rid="CR5">5</xref>]. Exercise may reduce fatigue and consequently improve a cancer survivors&#x02019; QoL [<xref ref-type="bibr" rid="CR40">40</xref>]. Cancer survivors with higher levels of fatigue at baseline may have more room for reducing their fatigue and consequently have larger improvements in global QoL.</p><p>We found no moderating effect of marital status. This is in contrast with the studies of Courneya et al. [<xref ref-type="bibr" rid="CR13">13</xref>, <xref ref-type="bibr" rid="CR14">14</xref>], who found a larger effect of exercise during cancer treatment on QoL in unmarried cancer survivors with breast cancer or lymphoma than in their counterparts. It has been suggested that unmarried cancer survivors may have less social support at home than married cancer survivors and consequently benefit more from the social group effect of the intervention [<xref ref-type="bibr" rid="CR41">41</xref>], resulting in larger improvements in global QoL [<xref ref-type="bibr" rid="CR42">42</xref>]. In contrast with the previous mentioned studies, cancer survivors in our intervention were included from 3&#x000a0;months after treatment. Perhaps, social support from a partner may be more important during treatment than after treatment. Cancer survivors who participated in our group-based rehabilitation program reported the support of fellow cancer survivors and the sharing of experiences to be an important part of the rehabilitation [<xref ref-type="bibr" rid="CR43">43</xref>]. It should also be noted that our results were based on a comparison between married and unmarried cancer survivors where 70&#x000a0;% in the exercise group and 90&#x000a0;% in the WLC group had a partner. This may bias our results, and therefore, our findings should be used with caution. Future studies should investigate the moderating role of social support from a partner or fellow cancer survivors of the physical exercise effect on global QoL.</p><p>Strengths of the present study are the supervised, standardized and theory-based exercise interventions, the high attendance rates, and the low dropout rates. However, this study had some limitations. First, participants were not randomly assigned to the WLC group. Nevertheless, the groups were well balanced in baseline physical and psychological outcomes, and we adjusted for relevant sociodemographic and clinical variables in all analyses. Second, although the sample size was relatively large for an exercise trial among cancer survivors, the original study was not powered to investigate moderators of intervention effect.This study showed that the sample size should be at least 395 to be able to adequately conduct stratified analyses with a power of 80&#x000a0;%. Therefore, our analyses of moderating effects should be interpreted as exploratory (hypothesis generating) post hoc analyses. Identifying for whom and under what circumstances specific exercise interventions improve the QoL is an important step toward the development of personalized exercise interventions [<xref ref-type="bibr" rid="CR44">44</xref>]. Future studies with large sample sizes are needed to confirm the moderating effects of being treated with radiotherapy or a combination chemoradiotherapy and fatigue and to provide insight into whether people with different demographic, clinical, and psychological characteristics indeed respond differently [<xref ref-type="bibr" rid="CR11">11</xref>, <xref ref-type="bibr" rid="CR45">45</xref>].</p><p>In conclusion, this study suggests that the physical exercise effects immediately after intervention on global QoL were larger in cancer survivors who received radiotherapy, and in particular, those who received a combination of chemoradiotherapy, and cancer survivors with higher baseline levels of fatigue compared to those who received no radiotherapy, no combination of chemoradiotherapy, and had lower baseline fatigue levels, respectively. Future studies with larger sample sizes and thus more power are needed to confirm the moderating effects of treatment regimens and fatigue.</p></sec></body><back><ack><p>We thank all participants and professional staff of participating institutes. This study was supported by a grant from the Dutch Cancer Society (UU-2000-2585), the Comprehensive Cancer Center, location Groningen and the Maastricht University. The contribution of L.M. Buffart and J. Kalter was further supported by the &#x0201c;Bas Mulder Award&#x0201d; granted to L.M. Buffart by the Alpe d&#x02019;HuZes foundation, part of the Dutch Cancer Society.</p><sec id="FPar4"><title>Conflict of interest</title><p>The authors declare to have no conflicts of interest.</p></sec></ack><ref-list id="Bib1"><title>References</title><ref id="CR1"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rowland</surname><given-names>JH</given-names></name><name><surname>Kent</surname><given-names>EE</given-names></name><name><surname>Forsythe</surname><given-names>LP</given-names></name><name><surname>Loge</surname><given-names>JH</given-names></name><name><surname>Hjorth</surname><given-names>L</given-names></name><name><surname>Glaser</surname><given-names>A</given-names></name><name><surname>Mattioli</surname><given-names>V</given-names></name><name><surname>Fossa</surname><given-names>SD</given-names></name></person-group><article-title>Cancer survivorship research in Europe and the United States: where have we been, where are we going, and what can we learn from each other?</article-title><source>Cancer</source><year>2013</year><volume>119</volume><issue>Suppl 11</issue><fpage>2094</fpage><lpage>2108</lpage><pub-id pub-id-type="doi">10.1002/cncr.28060</pub-id><pub-id pub-id-type="pmid">23695922</pub-id></element-citation></ref><ref id="CR2"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kamangar</surname><given-names>F</given-names></name><name><surname>Dores</surname><given-names>GM</given-names></name><name><surname>Anderson</surname><given-names>WF</given-names></name></person-group><article-title>Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world</article-title><source>J Clin Oncol</source><year>2006</year><volume>24</volume><fpage>2137</fpage><lpage>2150</lpage><pub-id pub-id-type="doi">10.1200/JCO.2005.05.2308</pub-id><pub-id pub-id-type="pmid">16682732</pub-id></element-citation></ref><ref id="CR3"><label>3.</label><mixed-citation publication-type="other">International Agency for Research on Cancer. GLOBOCAN 2012: estimated cancer incidence, mortality and prevalence worldwide in 2012. (2014). <ext-link ext-link-type="uri" xlink:href="http://globocan.iarc.fr/Pages/fact_sheets_cancer.aspx">http://globocan.iarc.fr/Pages/fact_sheets_cancer.aspx</ext-link>. Accessed 24 Feb 2014</mixed-citation></ref><ref id="CR4"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Courneya</surname><given-names>KS</given-names></name></person-group><article-title>Exercise in cancer survivors: an overview of research</article-title><source>Med Sci Sports Exerc</source><year>2003</year><volume>35</volume><fpage>1846</fpage><lpage>1852</lpage><pub-id pub-id-type="doi">10.1249/01.MSS.0000093622.41587.B6</pub-id><pub-id pub-id-type="pmid">14600549</pub-id></element-citation></ref><ref id="CR5"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Curt</surname><given-names>GA</given-names></name><name><surname>Breitbart</surname><given-names>W</given-names></name><name><surname>Cella</surname><given-names>D</given-names></name><name><surname>Groopman</surname><given-names>JE</given-names></name><name><surname>Horning</surname><given-names>SJ</given-names></name><name><surname>Itri</surname><given-names>LM</given-names></name><name><surname>Johnson</surname><given-names>DH</given-names></name><name><surname>Miaskowski</surname><given-names>C</given-names></name><name><surname>Scherr</surname><given-names>SL</given-names></name><name><surname>Portenoy</surname><given-names>RK</given-names></name><name><surname>Vogelzang</surname><given-names>NJ</given-names></name></person-group><article-title>Impact of cancer-related fatigue on the lives of patients: new findings from the Fatigue Coalition</article-title><source>Oncologist</source><year>2000</year><volume>5</volume><fpage>353</fpage><lpage>360</lpage><pub-id pub-id-type="doi">10.1634/theoncologist.5-5-353</pub-id><pub-id pub-id-type="pmid">11040270</pub-id></element-citation></ref><ref id="CR6"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mishra</surname><given-names>SI</given-names></name><name><surname>Scherer</surname><given-names>RW</given-names></name><name><surname>Geigle</surname><given-names>PM</given-names></name><name><surname>Berlanstein</surname><given-names>DR</given-names></name><name><surname>Topaloglu</surname><given-names>O</given-names></name><name><surname>Gotay</surname><given-names>CC</given-names></name><name><surname>Snyder</surname><given-names>C</given-names></name></person-group><article-title>Exercise interventions on health-related quality of life for cancer survivors</article-title><source>Cochrane Database Syst Rev</source><year>2012</year><volume>8</volume><pub-id pub-id-type="pmid">22895961</pub-id></element-citation></ref><ref id="CR7"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mishra</surname><given-names>SI</given-names></name><name><surname>Scherer</surname><given-names>RW</given-names></name><name><surname>Snyder</surname><given-names>C</given-names></name><name><surname>Geigle</surname><given-names>PM</given-names></name><name><surname>Berlanstein</surname><given-names>DR</given-names></name><name><surname>Topaloglu</surname><given-names>O</given-names></name></person-group><article-title>Exercise interventions on health-related quality of life for people with cancer during active treatment</article-title><source>Cochrane Database Syst Rev</source><year>2012</year><volume>8</volume><pub-id pub-id-type="pmid">22895974</pub-id></element-citation></ref><ref id="CR8"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Duijts</surname><given-names>SF</given-names></name><name><surname>Faber</surname><given-names>MM</given-names></name><name><surname>Oldenburg</surname><given-names>HS</given-names></name><name><surname>van Beurden</surname><given-names>M</given-names></name><name><surname>Aaronson</surname><given-names>NK</given-names></name></person-group><article-title>Effectiveness of behavioral techniques and physical exercise on psychosocial functioning and health-related quality of life in breast cancer patients and survivors&#x02014;a meta-analysis</article-title><source>Psychooncology</source><year>2011</year><volume>20</volume><fpage>115</fpage><lpage>126</lpage><pub-id pub-id-type="doi">10.1002/pon.1728</pub-id><pub-id pub-id-type="pmid">20336645</pub-id></element-citation></ref><ref id="CR9"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Speck</surname><given-names>RM</given-names></name><name><surname>Courneya</surname><given-names>KS</given-names></name><name><surname>Masse</surname><given-names>LC</given-names></name><name><surname>Duval</surname><given-names>S</given-names></name><name><surname>Schmitz</surname><given-names>KH</given-names></name></person-group><article-title>An update of controlled physical activity trials in cancer survivors: a systematic review and meta-analysis</article-title><source>J Cancer Surviv</source><year>2010</year><volume>4</volume><fpage>87</fpage><lpage>100</lpage><pub-id pub-id-type="doi">10.1007/s11764-009-0110-5</pub-id><pub-id pub-id-type="pmid">20052559</pub-id></element-citation></ref><ref id="CR10"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>May</surname><given-names>AM</given-names></name><name><surname>Korstjens</surname><given-names>I</given-names></name><name><surname>van Weert</surname><given-names>E</given-names></name><name><surname>van den Borne</surname><given-names>B</given-names></name><name><surname>Hoekstra-Weebers</surname><given-names>JE</given-names></name><name><surname>van der Schans</surname><given-names>CP</given-names></name><name><surname>Mesters</surname><given-names>I</given-names></name><name><surname>Passchier</surname><given-names>J</given-names></name><name><surname>Grobbee</surname><given-names>DE</given-names></name><name><surname>Ros</surname><given-names>WJ</given-names></name></person-group><article-title>Long-term effects on cancer survivors' quality of life of physical training versus physical training combined with cognitive-behavioral therapy: results from a randomized trial</article-title><source>Support Care Cancer</source><year>2009</year><volume>17</volume><fpage>653</fpage><lpage>663</lpage><pub-id pub-id-type="doi">10.1007/s00520-008-0519-9</pub-id><pub-id pub-id-type="pmid">18953578</pub-id></element-citation></ref><ref id="CR11"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Buffart</surname><given-names>LM</given-names></name><name><surname>Kalter</surname><given-names>J</given-names></name><name><surname>Chinapaw</surname><given-names>MJ</given-names></name><name><surname>Heymans</surname><given-names>MW</given-names></name><name><surname>Aaronson</surname><given-names>NK</given-names></name><name><surname>Courneya</surname><given-names>KS</given-names></name><name><surname>Jacobsen</surname><given-names>PB</given-names></name><name><surname>Newton</surname><given-names>RU</given-names></name><name><surname>Verdonck-de Leeuw</surname><given-names>IM</given-names></name><name><surname>Brug</surname><given-names>J</given-names></name></person-group><article-title>Predicting Optimal Cancer Rehabilitation and Supportive Care (POLARIS): rationale and design for meta-analyses of individual patient data of randomized controlled trials that evaluate the effect of physical activity and psychosocial interventions on health-related quality of life in cancer survivors</article-title><source>Syst Rev</source><year>2013</year><volume>2</volume><fpage>75</fpage><pub-id pub-id-type="doi">10.1186/2046-4053-2-75</pub-id><pub-id pub-id-type="pmid">24034173</pub-id></element-citation></ref><ref id="CR12"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kraemer</surname><given-names>HC</given-names></name><name><surname>Wilson</surname><given-names>GT</given-names></name><name><surname>Fairburn</surname><given-names>CG</given-names></name><name><surname>Agras</surname><given-names>WS</given-names></name></person-group><article-title>Mediators and moderators of treatment effects in randomized clinical trials</article-title><source>Arch Gen Psychiatry</source><year>2002</year><volume>59</volume><fpage>877</fpage><lpage>883</lpage><pub-id pub-id-type="doi">10.1001/archpsyc.59.10.877</pub-id><pub-id pub-id-type="pmid">12365874</pub-id></element-citation></ref><ref id="CR13"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Courneya</surname><given-names>KS</given-names></name><name><surname>McKenzie</surname><given-names>DC</given-names></name><name><surname>Mackey</surname><given-names>JR</given-names></name><name><surname>Gelmon</surname><given-names>K</given-names></name><name><surname>Reid</surname><given-names>RD</given-names></name><name><surname>Friedenreich</surname><given-names>CM</given-names></name><name><surname>Ladha</surname><given-names>AB</given-names></name><name><surname>Proulx</surname><given-names>C</given-names></name><name><surname>Vallance</surname><given-names>JK</given-names></name><name><surname>Lane</surname><given-names>K</given-names></name><name><surname>Yasui</surname><given-names>Y</given-names></name><name><surname>Segal</surname><given-names>RJ</given-names></name></person-group><article-title>Moderators of the effects of exercise training in breast cancer patients receiving chemotherapy: a randomized controlled trial</article-title><source>Cancer</source><year>2008</year><volume>112</volume><fpage>1845</fpage><lpage>1853</lpage><pub-id pub-id-type="doi">10.1002/cncr.23379</pub-id><pub-id pub-id-type="pmid">18306372</pub-id></element-citation></ref><ref id="CR14"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Courneya</surname><given-names>KS</given-names></name><name><surname>Sellar</surname><given-names>CM</given-names></name><name><surname>Stevinson</surname><given-names>C</given-names></name><name><surname>McNeely</surname><given-names>ML</given-names></name><name><surname>Friedenreich</surname><given-names>CM</given-names></name><name><surname>Peddle</surname><given-names>CJ</given-names></name><name><surname>Basi</surname><given-names>S</given-names></name><name><surname>Chua</surname><given-names>N</given-names></name><name><surname>Tankel</surname><given-names>K</given-names></name><name><surname>Mazurek</surname><given-names>A</given-names></name><name><surname>Reiman</surname><given-names>T</given-names></name></person-group><article-title>Moderator effects in a randomized controlled trial of exercise training in lymphoma patients</article-title><source>Cancer Epidemiol Biomarkers Prev</source><year>2009</year><volume>18</volume><fpage>2600</fpage><lpage>2607</lpage><pub-id pub-id-type="doi">10.1158/1055-9965.EPI-09-0504</pub-id><pub-id pub-id-type="pmid">19815635</pub-id></element-citation></ref><ref id="CR15"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Korstjens</surname><given-names>I</given-names></name><name><surname>May</surname><given-names>AM</given-names></name><name><surname>van Weert</surname><given-names>E</given-names></name><name><surname>Mesters</surname><given-names>I</given-names></name><name><surname>Tan</surname><given-names>F</given-names></name><name><surname>Ros</surname><given-names>WJ</given-names></name><name><surname>Hoekstra-Weebers</surname><given-names>JE</given-names></name><name><surname>van der Schans</surname><given-names>CP</given-names></name><name><surname>van den Borne</surname><given-names>B</given-names></name></person-group><article-title>Quality of life after self-management cancer rehabilitation: a randomized controlled trial comparing physical and cognitive-behavioral training versus physical training</article-title><source>Psychosom Med</source><year>2008</year><volume>70</volume><fpage>422</fpage><lpage>429</lpage><pub-id pub-id-type="doi">10.1097/PSY.0b013e31816e038f</pub-id><pub-id pub-id-type="pmid">18480190</pub-id></element-citation></ref><ref id="CR16"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van Weert</surname><given-names>E</given-names></name><name><surname>May</surname><given-names>AM</given-names></name><name><surname>Korstjens</surname><given-names>I</given-names></name><name><surname>Post</surname><given-names>WJ</given-names></name><name><surname>van der Schans</surname><given-names>CP</given-names></name><name><surname>van den Borne</surname><given-names>B</given-names></name><name><surname>Mesters</surname><given-names>I</given-names></name><name><surname>Ros</surname><given-names>WJ</given-names></name><name><surname>Hoekstra-Weebers</surname><given-names>JE</given-names></name></person-group><article-title>Cancer-related fatigue and rehabilitation: a randomized controlled multicenter trial comparing physical training combined with cognitive-behavioral therapy with physical training only and with no intervention</article-title><source>Phys Ther</source><year>2010</year><volume>90</volume><fpage>1413</fpage><lpage>1425</lpage><pub-id pub-id-type="doi">10.2522/ptj.20090212</pub-id><pub-id pub-id-type="pmid">20651011</pub-id></element-citation></ref><ref id="CR17"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>May</surname><given-names>AM</given-names></name><name><surname>Van Weert</surname><given-names>E</given-names></name><name><surname>Korstjens</surname><given-names>I</given-names></name><name><surname>Hoekstra-Weebers</surname><given-names>JE</given-names></name><name><surname>Van Der Schans</surname><given-names>CP</given-names></name><name><surname>Zonderland</surname><given-names>ML</given-names></name><name><surname>Mesters</surname><given-names>I</given-names></name><name><surname>Van Den Borne</surname><given-names>B</given-names></name><name><surname>Ros</surname><given-names>WD</given-names></name></person-group><article-title>Improved physical fitness of cancer survivors: a randomised controlled trial comparing physical training with physical and cognitive-behavioural training</article-title><source>Acta Oncol</source><year>2008</year><volume>47</volume><fpage>825</fpage><lpage>834</lpage><pub-id pub-id-type="doi">10.1080/02841860701666063</pub-id><pub-id pub-id-type="pmid">17917819</pub-id></element-citation></ref><ref id="CR18"><label>18.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Creer</surname><given-names>TL</given-names></name></person-group><source>Self-management of chronic illness. Handbook of self regulation</source><year>2002</year><publisher-loc>San Diego</publisher-loc><publisher-name>Academic</publisher-name></element-citation></ref><ref id="CR19"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bandura</surname><given-names>A</given-names></name></person-group><article-title>Health promotion by social cognitive means</article-title><source>Health Educ Behav</source><year>2004</year><volume>31</volume><fpage>143</fpage><lpage>164</lpage><pub-id pub-id-type="doi">10.1177/1090198104263660</pub-id><pub-id pub-id-type="pmid">15090118</pub-id></element-citation></ref><ref id="CR20"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nezu</surname><given-names>AM</given-names></name><name><surname>Nezu</surname><given-names>CM</given-names></name><name><surname>Felgoise</surname><given-names>SH</given-names></name><name><surname>McClure</surname><given-names>KS</given-names></name><name><surname>Houts</surname><given-names>PS</given-names></name></person-group><article-title>Project Genesis: assessing the efficacy of problem-solving therapy for distressed adult cancer patients</article-title><source>J Consult Clin Psychol</source><year>2003</year><volume>71</volume><fpage>1036</fpage><lpage>1048</lpage><pub-id pub-id-type="doi">10.1037/0022-006X.71.6.1036</pub-id><pub-id pub-id-type="pmid">14622079</pub-id></element-citation></ref><ref id="CR21"><label>21.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>D'Zurilla</surname><given-names>TJ</given-names></name><name><surname>Nezu</surname><given-names>AM</given-names></name></person-group><source>Problem-solving therapy: a positive approach to clinical intervention</source><year>2007</year><publisher-loc>New York</publisher-loc><publisher-name>Springer</publisher-name></element-citation></ref><ref id="CR22"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aaronson</surname><given-names>NK</given-names></name><name><surname>Ahmedzai</surname><given-names>S</given-names></name><name><surname>Bergman</surname><given-names>B</given-names></name><name><surname>Bullinger</surname><given-names>M</given-names></name><name><surname>Cull</surname><given-names>A</given-names></name><name><surname>Duez</surname><given-names>NJ</given-names></name><name><surname>Filiberti</surname><given-names>A</given-names></name><name><surname>Flechtner</surname><given-names>H</given-names></name><name><surname>Fleishman</surname><given-names>SB</given-names></name><name><surname>de Haes</surname><given-names>JC</given-names></name><etal/></person-group><article-title>The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology</article-title><source>J Natl Cancer Inst</source><year>1993</year><volume>85</volume><fpage>365</fpage><lpage>376</lpage><pub-id pub-id-type="doi">10.1093/jnci/85.5.365</pub-id><pub-id pub-id-type="pmid">8433390</pub-id></element-citation></ref><ref id="CR23"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Smets</surname><given-names>EM</given-names></name><name><surname>Garssen</surname><given-names>B</given-names></name><name><surname>Bonke</surname><given-names>B</given-names></name><name><surname>De Haes</surname><given-names>JC</given-names></name></person-group><article-title>The Multidimensional Fatigue Inventory (MFI) psychometric qualities of an instrument to assess fatigue</article-title><source>J Psychosom Res</source><year>1995</year><volume>39</volume><fpage>315</fpage><lpage>325</lpage><pub-id pub-id-type="doi">10.1016/0022-3999(94)00125-O</pub-id><pub-id pub-id-type="pmid">7636775</pub-id></element-citation></ref><ref id="CR24"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bosscher</surname><given-names>RJ</given-names></name><name><surname>Smit</surname><given-names>JH</given-names></name><name><surname>Kempen</surname><given-names>GI</given-names></name></person-group><article-title>Algemene competentieverwachtingen bij ouderen; een onderzoek naar de psychometrische kenmerken van de algemene competentieschaal (ALCOS) [in Dutch: general competency expectations in elderly; a study into the psychometric properties of the general competency scale]</article-title><source>Ned Tijdschr Psychol</source><year>1997</year><volume>52</volume><fpage>239</fpage><lpage>248</lpage></element-citation></ref><ref id="CR25"><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zigmond</surname><given-names>AS</given-names></name><name><surname>Snaith</surname><given-names>RP</given-names></name></person-group><article-title>The hospital anxiety and depression scale</article-title><source>Acta Psychiatr Scand</source><year>1983</year><volume>67</volume><fpage>361</fpage><lpage>370</lpage><pub-id pub-id-type="doi">10.1111/j.1600-0447.1983.tb09716.x</pub-id><pub-id pub-id-type="pmid">6880820</pub-id></element-citation></ref><ref id="CR26"><label>26.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Spinhoven</surname><given-names>P</given-names></name><name><surname>Ormel</surname><given-names>J</given-names></name><name><surname>Sloekers</surname><given-names>PP</given-names></name><name><surname>Kempen</surname><given-names>GI</given-names></name><name><surname>Speckens</surname><given-names>AE</given-names></name><name><surname>Van Hemert</surname><given-names>AM</given-names></name></person-group><article-title>A validation study of the Hospital Anxiety and Depression Scale (HADS) in different groups of Dutch subjects</article-title><source>Psychol Med</source><year>1997</year><volume>27</volume><fpage>363</fpage><lpage>370</lpage><pub-id pub-id-type="doi">10.1017/S0033291796004382</pub-id><pub-id pub-id-type="pmid">9089829</pub-id></element-citation></ref><ref id="CR27"><label>27.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vodermaier</surname><given-names>A</given-names></name><name><surname>Linden</surname><given-names>W</given-names></name><name><surname>Siu</surname><given-names>C</given-names></name></person-group><article-title>Screening for emotional distress in cancer patients: a systematic review of assessment instruments</article-title><source>J Natl Cancer Inst</source><year>2009</year><volume>101</volume><fpage>1464</fpage><lpage>1488</lpage><pub-id pub-id-type="doi">10.1093/jnci/djp336</pub-id><pub-id pub-id-type="pmid">19826136</pub-id></element-citation></ref><ref id="CR28"><label>28.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bjelland</surname><given-names>I</given-names></name><name><surname>Dahl</surname><given-names>AA</given-names></name><name><surname>Haug</surname><given-names>TT</given-names></name><name><surname>Neckelmann</surname><given-names>D</given-names></name></person-group><article-title>The validity of the hospital anxiety and depression scale. An updated literature review</article-title><source>J Psychosom Res</source><year>2002</year><volume>52</volume><fpage>69</fpage><lpage>77</lpage><pub-id pub-id-type="doi">10.1016/S0022-3999(01)00296-3</pub-id><pub-id pub-id-type="pmid">11832252</pub-id></element-citation></ref><ref id="CR29"><label>29.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aguinis</surname><given-names>H</given-names></name><name><surname>Petersen</surname><given-names>SA</given-names></name><name><surname>Pierce</surname><given-names>CA</given-names></name></person-group><article-title>Appraisal of the homogeneity of error variance assumption and alternatives to multiple regression for estimating moderating effects of categorical variables</article-title><source>Organ Res Methods</source><year>1999</year><volume>2</volume><fpage>315</fpage><lpage>339</lpage><pub-id pub-id-type="doi">10.1177/109442819924001</pub-id></element-citation></ref><ref id="CR30"><label>30.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>DeShon</surname><given-names>RP</given-names></name><name><surname>Alexander</surname><given-names>RA</given-names></name></person-group><article-title>Alternative procedures for testing regression slope homogeneity when group error variances are unequal</article-title><source>Psychol Methods</source><year>1996</year><volume>1</volume><fpage>261</fpage><lpage>277</lpage><pub-id pub-id-type="doi">10.1037/1082-989X.1.3.261</pub-id></element-citation></ref><ref id="CR31"><label>31.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Snedecor</surname><given-names>GW</given-names></name><name><surname>Cochran</surname><given-names>WG</given-names></name></person-group><source>Statistical methods</source><year>1989</year><edition>8</edition><publisher-loc>Ames</publisher-loc><publisher-name>Iowa State University Press</publisher-name></element-citation></ref><ref id="CR32"><label>32.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>James</surname><given-names>GS</given-names></name></person-group><article-title>Tests of linear hypotheses in univariate and multivariate analysis when the ratios of the population variances are unknown</article-title><source>Biometrika</source><year>1954</year><volume>41</volume><fpage>19</fpage><lpage>43</lpage></element-citation></ref><ref id="CR33"><label>33.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alexander</surname><given-names>RA</given-names></name><name><surname>Govern</surname><given-names>DM</given-names></name></person-group><article-title>A new and simpler approximation for Anova under variance heterogeneity</article-title><source>J Educ Stat</source><year>1994</year><volume>19</volume><fpage>91</fpage><lpage>101</lpage><pub-id pub-id-type="doi">10.2307/1165140</pub-id></element-citation></ref><ref id="CR34"><label>34.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aguinis</surname><given-names>H</given-names></name><name><surname>Pierce</surname><given-names>CA</given-names></name><name><surname>Stoneromero</surname><given-names>EF</given-names></name></person-group><article-title>Estimating the power to detect dichotomous moderators with moderated multiple-regression</article-title><source>Educ Psychol Meas</source><year>1994</year><volume>54</volume><fpage>690</fpage><lpage>692</lpage><pub-id pub-id-type="doi">10.1177/0013164494054003013</pub-id></element-citation></ref><ref id="CR35"><label>35.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Faul</surname><given-names>F</given-names></name><name><surname>Erdfelder</surname><given-names>E</given-names></name><name><surname>Buchner</surname><given-names>A</given-names></name><name><surname>Lang</surname><given-names>AG</given-names></name></person-group><article-title>Statistical power analyses using G*Power 3.1: tests for correlation and regression analyses</article-title><source>Behav Res Methods</source><year>2009</year><volume>41</volume><fpage>1149</fpage><lpage>1160</lpage><pub-id pub-id-type="doi">10.3758/BRM.41.4.1149</pub-id><pub-id pub-id-type="pmid">19897823</pub-id></element-citation></ref><ref id="CR36"><label>36.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Diggle</surname><given-names>P</given-names></name><name><surname>Heagerty</surname><given-names>P</given-names></name><name><surname>Liang</surname><given-names>K-Y</given-names></name><name><surname>Zeger</surname><given-names>S</given-names></name></person-group><source>Analysis of longitudinal data</source><year>2002</year><publisher-loc>Oxford</publisher-loc><publisher-name>Oxford University Press</publisher-name></element-citation></ref><ref id="CR37"><label>37.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Cohen</surname><given-names>J</given-names></name></person-group><source>Statistical power analysis for the behavioral sciences</source><year>1988</year><edition>2</edition><publisher-loc>Hillsdale</publisher-loc><publisher-name>Lawrence Earlbaum Associates</publisher-name></element-citation></ref><ref id="CR38"><label>38.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Osoba</surname><given-names>D</given-names></name><name><surname>Rodrigues</surname><given-names>G</given-names></name><name><surname>Myles</surname><given-names>J</given-names></name><name><surname>Zee</surname><given-names>B</given-names></name><name><surname>Pater</surname><given-names>J</given-names></name></person-group><article-title>Interpreting the significance of changes in health-related quality-of-life scores</article-title><source>J Clin Oncol</source><year>1998</year><volume>16</volume><fpage>139</fpage><lpage>144</lpage><pub-id pub-id-type="pmid">9440735</pub-id></element-citation></ref><ref id="CR39"><label>39.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yucel</surname><given-names>B</given-names></name><name><surname>Akkas</surname><given-names>EA</given-names></name><name><surname>Okur</surname><given-names>Y</given-names></name><name><surname>Eren</surname><given-names>AA</given-names></name><name><surname>Eren</surname><given-names>MF</given-names></name><name><surname>Karapinar</surname><given-names>H</given-names></name><name><surname>Babacan</surname><given-names>NA</given-names></name><name><surname>Kilickap</surname><given-names>S</given-names></name></person-group><article-title>The impact of radiotherapy on quality of life for cancer patients: a longitudinal study</article-title><source>Support Care Cancer</source><year>2014</year><volume>22</volume><fpage>2479</fpage><lpage>2487</lpage><pub-id pub-id-type="doi">10.1007/s00520-014-2235-y</pub-id><pub-id pub-id-type="pmid">24728584</pub-id></element-citation></ref><ref id="CR40"><label>40.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Buffart</surname><given-names>LM</given-names></name><name><surname>Ros</surname><given-names>WJ</given-names></name><name><surname>Chinapaw</surname><given-names>MJ</given-names></name><name><surname>Brug</surname><given-names>J</given-names></name><name><surname>Knol</surname><given-names>DL</given-names></name><name><surname>Korstjens</surname><given-names>I</given-names></name><name><surname>van Weert</surname><given-names>E</given-names></name><name><surname>Mesters</surname><given-names>I</given-names></name><name><surname>van den Borne</surname><given-names>B</given-names></name><name><surname>Hoekstra-Weebers</surname><given-names>JE</given-names></name><name><surname>May</surname><given-names>AM</given-names></name></person-group><article-title>Mediators of physical exercise for improvement in cancer survivors&#x02019; quality of life</article-title><source>Psychooncology</source><year>2014</year><volume>23</volume><fpage>330</fpage><lpage>338</lpage><pub-id pub-id-type="doi">10.1002/pon.3428</pub-id><pub-id pub-id-type="pmid">24123482</pub-id></element-citation></ref><ref id="CR41"><label>41.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Osborne</surname><given-names>C</given-names></name><name><surname>Ostir</surname><given-names>GV</given-names></name><name><surname>Du</surname><given-names>X</given-names></name><name><surname>Peek</surname><given-names>MK</given-names></name><name><surname>Goodwin</surname><given-names>JS</given-names></name></person-group><article-title>The influence of marital status on the stage at diagnosis, treatment, and survival of older women with breast cancer</article-title><source>Breast Cancer Res Treat</source><year>2005</year><volume>93</volume><fpage>41</fpage><lpage>47</lpage><pub-id pub-id-type="doi">10.1007/s10549-005-3702-4</pub-id><pub-id pub-id-type="pmid">16184457</pub-id></element-citation></ref><ref id="CR42"><label>42.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Graves</surname><given-names>KD</given-names></name></person-group><article-title>Social cognitive theory and cancer patients&#x02019; quality of life: a meta-analysis of psychosocial intervention components</article-title><source>Health Psychol</source><year>2003</year><volume>22</volume><fpage>210</fpage><lpage>219</lpage><pub-id pub-id-type="doi">10.1037/0278-6133.22.2.210</pub-id><pub-id pub-id-type="pmid">12683741</pub-id></element-citation></ref><ref id="CR43"><label>43.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Korstjens</surname><given-names>I</given-names></name><name><surname>Mesters</surname><given-names>I</given-names></name><name><surname>Gijsen</surname><given-names>B</given-names></name><name><surname>van den Borne</surname><given-names>B</given-names></name></person-group><article-title>Cancer patients&#x02019; view on rehabilitation and quality of life: a programme audit</article-title><source>Eur J Cancer Care (Engl)</source><year>2008</year><volume>17</volume><fpage>290</fpage><lpage>297</lpage><pub-id pub-id-type="doi">10.1111/j.1365-2354.2007.00864.x</pub-id><pub-id pub-id-type="pmid">18419633</pub-id></element-citation></ref><ref id="CR44"><label>44.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Buffart</surname><given-names>LM</given-names></name><name><surname>Galvao</surname><given-names>DA</given-names></name><name><surname>Brug</surname><given-names>J</given-names></name><name><surname>Chinapaw</surname><given-names>MJ</given-names></name><name><surname>Newton</surname><given-names>RU</given-names></name></person-group><article-title>Evidence-based physical activity guidelines for cancer survivors: current guidelines, knowledge gaps and future research directions</article-title><source>Cancer Treat Rev</source><year>2014</year><volume>40</volume><fpage>327</fpage><lpage>340</lpage><pub-id pub-id-type="doi">10.1016/j.ctrv.2013.06.007</pub-id><pub-id pub-id-type="pmid">23871124</pub-id></element-citation></ref><ref id="CR45"><label>45.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Courneya</surname><given-names>KS</given-names></name></person-group><article-title>Physical activity and cancer survivorship: a simple framework for a complex field</article-title><source>Exerc Sport Sci Rev</source><year>2014</year><volume>42</volume><fpage>102</fpage><lpage>109</lpage><pub-id pub-id-type="doi">10.1249/JES.0000000000000011</pub-id><pub-id pub-id-type="pmid">24508735</pub-id></element-citation></ref></ref-list></back></article>